Sun Pharmaceutical Industries Share Price Today - Live Blog for November 20, 2025

Sun Pharmaceutical Industries Ltd's share price remained steady, showing no variations, and is currently at ₹1,775.95. While the stock's performance remains consistent, it's worth noting that its PE ratio is 40.2700, while the industry PE is 33.5124.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.18%, a situation worth noting. At present, the stock is trading at ₹1,775.95. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 40.2700, while the industry PE ratio is 33.5124.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.12% uptick, and they are currently valued at ₹1,780.10, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0670 and an ROE of 14.8407%.

With a -0.03% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,777.55. Investors should examine the factors driving this decline. The stock's PE ratio is 40.2700, whereas the industry PE ratio stands at 33.5124.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.27%, signalling a challenging period. Currently trading at ₹1,778.05, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -0.02% drop, and it's now trading at ₹1,781.95 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Sun Pharmaceutical Industries Ltd share price has declined by -0.00%, and it's currently trading at ₹1,782.30. The stock maintains a PE of 40.2700, while the industry PE is 33.5124, prompting discussions about its valuation.

After a -0.00% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,782.30. The stock has a PE ratio of 40.2700, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.02% decline, and it currently trades at ₹1,783.60 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The share price of Sun Pharmaceutical Industries Ltd experienced an uptrend, surging by 0.21% recently. As of now, this stock is actively trading at a current market price of ₹1,783.25 per share, attracting attention from investors.

Sun Pharmaceutical Industries Ltd's stock has surged by 0.21%, and it is currently trading at ₹1,783.25. Additionally, the stock maintains a PE ratio of 40.2700, while the industry PE is 33.5124.

With a remarkable 0.24% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,780.55. Notably, this stock has a Price-to-Earnings (PE) ratio of 40.2700, while the industry's PE ratio is 33.5124.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.02% drop, and it's now trading at ₹1,775.45 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

With a -0.14% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,773.40. The stock is currently trading at a PE of 40.2700, while the industry PE is 33.5124, prompting investors to assess its value proposition.

Sun Pharmaceutical Industries Ltd shares experienced a -0.32% reduction, with the current market price at ₹1,776.20. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.04% gain, with the share price now at ₹1,781.95. Notably, the stock's PE ratio stands at 40.2700, and its Return on Equity (ROE) is 14.8407%.

Sun Pharmaceutical Industries Ltd share price has declined by -0.09%, and it's currently trading at ₹1,779.25. The stock maintains a PE of 40.2700, while the industry PE is 33.5124, prompting discussions about its valuation.

Sun Pharmaceutical Industries Ltd's stock price surged by 0.30%, reaching the current market value of ₹1,780.90 per share. This surge is a testament to the stock's recent performance.

Sun Pharmaceutical Industries Ltd observed a -0.05% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,774.40. The stock has a PE ratio of 40.2700, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.08% uptick, and they are currently valued at ₹1,779.40, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0670 and an ROE of 14.8407%.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.08%, and as of now, it's trading at ₹1,779.40 per share. This upward trajectory is attracting keen interest from investors.

Investors are buzzing as Sun Pharmaceutical Industries Ltd's share price soared by an impressive 0.08%. At this moment, it's actively trading at ₹1,779.40, presenting an enticing opportunity for those in the market.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.08% increase and currently trading at ₹1,779.40 per share. This upward trajectory is turning heads in the market.

Investors are buzzing as Sun Pharmaceutical Industries Ltd's share price soared by an impressive 0.12%. At this moment, it's actively trading at ₹1,777.00, presenting an enticing opportunity for those in the market.

The share price of Sun Pharmaceutical Industries Ltd recently experienced a positive upturn, resulting in a 0.12% increase. Presently, it is actively trading at ₹1,777.00.

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.30% decline and is currently trading at ₹1,776.05 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Sun Pharmaceutical Industries Ltd experienced a -0.30% downturn in its share price, and it's currently trading at ₹1,776.05. This situation is generating interest among value investors who are evaluating the stock's potential.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.08% slump and is currently trading at ₹1,779.80. While the stock maintains a PE ratio of 40.2700, the industry PE is 33.5124, raising questions about valuation.

With a -0.31% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,781.50. Investors should examine the factors driving this decline. The stock's PE ratio is 40.2700, whereas the industry PE ratio stands at 33.5124.

Sun Pharmaceutical Industries Ltd experienced a -0.23% dip in its share price and is currently trading at ₹1,785.85. The stock has a PE ratio of 40.2700, an ROE of 14.8407% and a debt to equity ratio of 0.0670.